The Scientist will be someone that can approach the
challenge of discovering and developing biomarker strategies
and measurements in support of pre-clinical and clinical
studies for Alzheimer's Disease and Mood Disorders. This
position has a focus on both supervision of laboratory
personnel and personal research responsibilities in the
biomarker pilot laboratory.
The Neuroscience Biomarker Scientist will be a member of
the Neuroscience Biomarkers team, and will be responsible
for the evaluation of potential biomarkers for their
application in clinical trials and as diagnostics. This
position will participate in the creation and execution of
biomarker strategies for therapies under development for the
treatment of neurologic and psychiatric disorders and pain.
He/she will also direct activities related to the validation
and qualification of biomarkers to be developed as assays
for clinical studies or diagnostics.
This position will be expected to interface and
collaborate with academia, pre-competitive industrial
consortia (such as ADNI, BIRN, FNIH, etc.) and commercial
vendors to ensure optimal support of neuroscience biomarker
and diagnostic capabilities. The Neuroscience Biomarker
expert will also interface with internal and external
experts in pharmacogenomics, proteomics, transcriptomics,
metabalomics, neuroimaging and other biomarker platforms to
contribute to multimodal biomarker strategies.
The successful candidate will be expected to track the
evolving landscape of neurologic and neuropsychiatric
disease biomarker technology—including cutting-edge research
in academic labs, potentially competitive capabilities in
start-up ventures, and the various R&D pipelines of the
major biotechnology vendors.
Collaboration with preclinical scientists and clinical
experts will also be expected.